PH94B is being developed by Pherin Pharmaceuticals, Inc. for the treatment of social phobias (generalized anxiety disorder). It is a member of a new family of pharmaceutical compounds called vomeropherins.
Intended for the acute treatment of social phobia.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.